Ipsen S.A. (EPA:IPN)
165.80
+8.60 (5.47%)
Jul 31, 2026, 11:53 AM CET
Ipsen Market Cap
Ipsen has a market cap or net worth of €12.89 billion as of July 31, 2026. Its market cap has increased by 38.98% in one year.
Market Cap
12.89B
Enterprise Value
11.68B
Revenue
4.29B
Ranking
n/a
PE Ratio
25.48
Stock Price
€165.80
ChartMarket Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 12.89B, an increase of 625.72%. That is a compound annual growth rate of 10.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 12.89B | 31.92% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 96.07B |
| EssilorLuxottica Société anonyme | 75.88B |
| Sartorius Stedim Biotech | 16.66B |
| Eurofins Scientific SE | 11.92B |
| ABIVAX Société Anonyme | 9.34B |
| bioMérieux | 8.59B |
| Virbac | 2.91B |
| emeis Société anonyme | 2.24B |